Concepedia

Seth Rosen

SR

Statistics

Publications

8

Citations

276

H-Index

8

Active since

1993

Affiliations

Hematology Oncology Associates(Current)

University of Michigan

The Barbara Ann Karmanos Cancer Institute

Mary Crowley Cancer Research Center

McGill University Health Centre

Seth Rosen is an author at Hematology Oncology Associates specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1993–2025

8

Publications

8

Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies

Gerald S. Falchook, Seth Rosen, Patricia LoRusso et al. · Clinical Cancer Research · 2019 · 79 citations

, , +10

A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial

Yuxiang Ma, Yunpeng Yang, Yan Huang et al. · Nature Medicine · 2025 · 76 citations · Full text

, , +17

Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1.

Ulka N. Vaishampayan, Piotr Tomczak, Jameel Muzaffar et al. · Journal of Clinical Oncology · 2022 · 38 citations

, , +17

Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1)

Ulka N. Vaishampayan, Jameel Muzaffar, Ira Winer et al. · Journal for ImmunoTherapy of Cancer · 2024 · 29 citations · Full text

, , +17

Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors

Aung Naing, Alain P. Algazi, Gerald S. Falchook et al. · Cancer · 2022 · 18 citations · Full text

, , +17

1–5 of 8